Go Pro
NASDAQ:PETS

PetMed Express (PETS) Stock Price, News & Analysis

PetMed Express logo
$1.95 -0.03 (-1.52%)
Closing price 04:00 PM Eastern
Extended Trading
$1.95 0.00 (-0.05%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About PetMed Express Stock (NASDAQ:PETS)

Advanced

Key Stats

Today's Range
$1.95
$2.00
50-Day Range
$1.68
$2.23
52-Week Range
$1.57
$4.10
Volume
77,149 shs
Average Volume
130,775 shs
Market Capitalization
$41.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

PetMed Express, Inc. operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications. The company launched its initial public offering in 2000 and has since developed an in‐house team of veterinarians and pharmacy professionals to review prescriptions and provide customer support. With a multi‐channel approach that includes online ordering, telephone service and direct mail catalogs, PetMed Express seeks to simplify the process of obtaining essential pet health products.

PetMed Express primarily serves customers across the United States, with select offerings available in Canada. Its operations center around a fulfillment facility in Florida, supported by a network of third‐party carriers for nationwide delivery. The company is led by its founder and Chief Executive Officer, Marc Puleo, who oversees strategy and business development alongside a management team experienced in pharmaceutical distribution and e-commerce. PetMed Express continues to focus on expanding its product portfolio, enhancing digital capabilities and maintaining compliance with regulatory standards in veterinary pharmacy.

AI Generated. May Contain Errors.

PetMed Express Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
34th Percentile Overall Score

PETS MarketRank™: 

PetMed Express scored higher than 34% of companies evaluated by MarketBeat, and ranked 369th out of 482 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    PetMed Express has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    PetMed Express has only been the subject of 1 research reports in the past 90 days.

  • Read more about PetMed Express' stock forecast and price target.
  • Earnings Growth

    Earnings for PetMed Express are expected to grow by 28.57% in the coming year, from $0.07 to $0.09 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of PetMed Express is -0.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of PetMed Express is -0.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    PetMed Express has a P/B Ratio of 1.44. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about PetMed Express' valuation and earnings.
  • Percentage of Shares Shorted

    4.33% of the float of PetMed Express has been sold short.
  • Short Interest Ratio / Days to Cover

    PetMed Express has a short interest ratio ("days to cover") of 3.72, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in PetMed Express has recently decreased by 43.49%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    PetMed Express does not currently pay a dividend.

  • Dividend Growth

    PetMed Express does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on EPS estimates, PetMed Express will have a dividend payout ratio of 1,000.00% in the coming year. This indicates that PetMed Express may not be able to sustain their current dividend.

  • News Sentiment

    PetMed Express has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Consumer Discretionary companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for PetMed Express this week, compared to 2 articles on an average week.
  • Search Interest

    Only 4 people have searched for PETS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, PetMed Express insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    1.30% of the stock of PetMed Express is held by insiders.

  • Percentage Held by Institutions

    73.33% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about PetMed Express' insider trading history.
Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PETS Stock News Headlines

Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
See More Headlines

PETS Stock Analysis - Frequently Asked Questions

PetMed Express' stock was trading at $3.20 at the start of the year. Since then, PETS shares have decreased by 39.1% and is now trading at $1.95.

PetMed Express, Inc. (NASDAQ:PETS) posted its quarterly earnings data on Tuesday, June, 2nd. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by $0.01. The business earned $42.82 million during the quarter, compared to the consensus estimate of $52 million. PetMed Express had a negative trailing twelve-month return on equity of 76.86% and a negative net margin of 32.00%.
Read the conference call transcript
.

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PetMed Express investors own include Meta Platforms (META), NVIDIA (NVDA), Intel (INTC), Pfizer (PFE), Walt Disney (DIS), Ford Motor (F) and PayPal (PYPL).

Company Calendar

Last Earnings
6/02/2026
Today
7/31/2026
AGM 2026
8/11/2026
Next Earnings (Estimated)
10/13/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Specialty Retail
Sub-Industry
Other Specialty Retail
Current Symbol
NASDAQ:PETS
CIK
1040130
Employees
210
Year Founded
1996

Profitability

EPS (Trailing Twelve Months)
($2.75)
Trailing P/E Ratio
N/A
Forward P/E Ratio
27.86
P/E Growth
N/A
Net Income
-$57.29 million
Net Margins
-32.00%
Pretax Margin
-32.04%
Return on Equity
-76.86%
Return on Assets
-31.67%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.84
Quick Ratio
0.58

Sales & Book Value

Annual Sales
$179.02 million
Price / Sales
0.23
Cash Flow
$0.30 per share
Price / Cash Flow
6.40
Book Value
$1.35 per share
Price / Book
1.44

Miscellaneous

Outstanding Shares
21,370,000
Free Float
21,094,000
Market Cap
$41.67 million
Optionable
Optionable
Beta
0.77

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:PETS) was last updated on 7/31/2026 by MarketBeat.com Staff.
From Our Partners